This company listing is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Clovis Oncology Bilan de santé
Santé financière contrôle des critères 0/6
Clovis Oncology has a total shareholder equity of $-417.9M and total debt of $660.4M, which brings its debt-to-equity ratio to -158%. Its total assets and total liabilities are $346.8M and $764.7M respectively.
Informations clés
-158.0%
Ratio d'endettement
US$660.38m
Dette
| Ratio de couverture des intérêts | n/a |
| Argent liquide | US$58.32m |
| Fonds propres | -US$417.89m |
| Total du passif | US$764.66m |
| Total des actifs | US$346.78m |
Mises à jour récentes de la santé financière
Recent updates
Analyse de la situation financière
Passif à court terme: C6O has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Passif à long terme: C6O has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Historique et analyse du ratio d'endettement
Niveau d'endettement: C6O has negative shareholder equity, which is a more serious situation than a high debt level.
Réduire la dette: C6O's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: Insufficient data to determine if C6O has enough cash runway based on its current free cash flow.
Prévisions de trésorerie: Insufficient data to determine if C6O has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.